Cialis, Ambien CR top sites driving prescription requests, study says

Share this article:
Lilly Icos’ Cialis was identified as the pharmaceutical product site with the highest percent of visitors requesting a prescription after visiting, a new study says. Cialis was followed by Pfizer’s Viagra, AstraZeneca’s Nexium, Sepracor’s Lunesta and Sanofi-Aventis’ Allegra respectively, according to the results of the study conducted by market research firm Manhattan Research. The study, titled ePharma Consumer v6.0: The Future of Integrated DTC Marketing, provides data on over 100 pharmaceutical product sites and consumer actions as polled from 4,965 US adults. The Manhattan Research study further identified Sanofi-Aventis’ Ambien CR Web site as the top Rx product site driving prescription requests after visiting the site by prescription volume. Ambien CR was followed by Sanofi-Aventis’ Allegra, GlaxoSmithKline’s Wellbutrin XL, Sepracor’s Lunesta and AstraZeneca’s Lunesta respectively. Further details of the ePharma Consumer v6.0 study will be made available during a Webinar being offered by Manhattan Research today.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.